Print
HVTN 052
A Phase IB Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP, Administered at 2 Different Dosing Schedules, in HIV-1-Uninfected Adult Participants
Trial Details:
Phase:
Ib
Status:
Completed
Organizer developer:
HIV Vaccine Trials Network (HVTN)
Start Date:
December 01, 2003
Product:
VRC-HIVDNA009-00-VP
Antigen:
gag B, gol B, nef B, env A, env B, env C
Prime 1:
VRC-HIVDNA009-00-VP
Prime Class:
DNA
Boost 1:
Boost 1 class:
Boost 2:
Boost 2 Class:
Boost 3:
Boost 3 Class:
Adjuvant:
Country:
USA
Volunteers:
180
ClinicalTrials.gov Identifier:
NCT00071851
Link:
http://clinicaltrials.gov/show/NCT00071851